GLP-2 (human) is primarily used in medical and therapeutic applications due to its role in promoting intestinal growth and function. It is particularly effective in treating conditions like short bowel syndrome (SBS), where it enhances nutrient absorption by increasing the surface area of the intestinal lining. This peptide also supports gut health by reducing inflammation and improving barrier function, making it valuable in managing inflammatory bowel diseases (IBD) such as Crohn’s disease. Additionally, GLP-2 has shown potential in treating conditions like osteoporosis, as it may improve bone density by enhancing calcium absorption in the intestines. Its ability to stimulate cell proliferation and repair in the gastrointestinal tract makes it a promising candidate for further research in regenerative medicine and gastrointestinal disorders.